Anemia, Healthy
Conditions
Brief summary
The primary objective of this clinical investigation is to report on the repeatability and reproducibility of SpHb measurements from Rad-67 devices and DCI Mini sensors used to screen prospective blood donors at a donation center.
Interventions
Noninvasive pulse oximeter that measures hemoglobin
Sponsors
Study design
Eligibility
Inclusion criteria
* At least 18 years of age * Weight at least 110 pounds * Subjects with the intention of being screened for eligibility to donate blood * The subject has given written informed consent to participate in the study
Exclusion criteria
* Subjects with skin abnormalities at the planned application sites that may interfere with sensor application, per directions-for-use (DFU) or trans-illumination of the site, such as burns, scar tissue, infections, abnormalities, etc. * Subjects unwilling to remove nail polish or acrylic nails * Subjects with blood cancers such as leukemia * Subjects with hemoglobin disorders such as sickle-cell anemia and thalassemia or with known history of infectious diseases such as HIV/AIDS, syphilis, hepatitis, etc. * Subjects with self-disclosed/known pregnancy at the time of enrollment * Subjects deemed not suitable for the study at the discretion of the investigator * Subjects unlikely to be able to refrain from excessive motion during data collection. Excessive motion includes postural changes, making hand gestures, involuntary muscular movements, etc.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Coefficient of Variation of Rad-67 | Approximately 90 minutes per subject | Coefficient of variation will be computed using Repeatability and Reproducibility variance. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Test Subjects All subjects are enrolled and receive Rad-67 Pulse oximeter & DCI Mini sensor for measurement of hemoglobin.
Rad-67 Pulse oximeter & DCI Mini sensor: Noninvasive pulse oximeter that measures hemoglobin | 26 |
| Total | 26 |
Baseline characteristics
| Characteristic | Test Subjects |
|---|---|
| Age, Categorical <=18 years | 1 Participants |
| Age, Categorical >=65 years | 2 Participants |
| Age, Categorical Between 18 and 65 years | 23 Participants |
| Race/Ethnicity, Customized Race Asian | 2 Participants |
| Race/Ethnicity, Customized Race Black or African American | 1 Participants |
| Race/Ethnicity, Customized Race Mexican | 7 Participants |
| Race/Ethnicity, Customized Race Middle Eastern | 1 Participants |
| Race/Ethnicity, Customized Race More Than One Race | 1 Participants |
| Race/Ethnicity, Customized Race Native Hawaiian or Other Pacific Islander | 1 Participants |
| Race/Ethnicity, Customized Race Unknown or Not Reported | 1 Participants |
| Race/Ethnicity, Customized Race White | 12 Participants |
| Region of Enrollment United States | 26 participants |
| Sex: Female, Male Female | 15 Participants |
| Sex: Female, Male Male | 11 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 26 |
| other Total, other adverse events | 0 / 26 |
| serious Total, serious adverse events | 0 / 26 |
Outcome results
Coefficient of Variation of Rad-67
Coefficient of variation will be computed using Repeatability and Reproducibility variance.
Time frame: Approximately 90 minutes per subject
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Test Subjects | Coefficient of Variation of Rad-67 | 4.50 Coefficient of Variation percentage |